Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease

Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc..

PURPOSE: To better understand the development of dysphagia in patients with Parkinson disease (PD) and to identify possible neuromodulatory target regions of dysphagia, we studied the striatal dopamine transporter (DAT) availability distribution by subtype of dysphagia.

METHODS: In this retrospective cross-sectional study, patients with PD who underwent videofluoroscopic swallowing study and N-(3-[18F]fluoropropyl)-2β-carbon ethoxy-3β-(4-iodophenyl) nortropane (18F-FP-CIT) PET at intervals of less than 1 month were analyzed. The 14 binarized subitem scores of the Videofluoroscopic Dysphagia Scale were analyzed using a voxel-wise Firth's penalized binary logistic regression model, adjusting for age and disease duration at videofluoroscopic swallowing study.

RESULTS: Sixty-five patients with PD were finally included. Striatal mapping showed association of decreased DAT availability with 5 subitems with 1 or more clusters surviving the statistical threshold: 1 oral phase and 4 pharyngeal phase subitems. The overlap maps created by superimposing clusters for all 5 statistically significant subitems revealed associations of dysphagia in PD with decreased DAT availability in the bilateral ventral striatum. Of these, 4 subitems belonging to the pharyngeal phase-specific dysphagia were additionally found to be related to dopaminergic degeneration of the bilateral anterior-to-posterior caudate and ventral striatum.

CONCLUSIONS: These findings suggest that subitem/phase-specific striatal subregional dopaminergic depletion may explain the dysphagia of PD. This dopaminergic degeneration of striatal subregions specific to the phases of dysphagia may serve as a potential target for neuromodulatory brain stimulation through stimulation of cortices functionally connected.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:48

Enthalten in:

Clinical nuclear medicine - 48(2023), 2 vom: 01. Feb., Seite 143-149

Sprache:

Englisch

Beteiligte Personen:

Kim, Ji Hwan [VerfasserIn]
Jeon, Jonghu [VerfasserIn]
Lee, Young [VerfasserIn]
Kim, Seung Min [VerfasserIn]
Cheon, Miju [VerfasserIn]
Kim, Jun Yup [VerfasserIn]

Links:

Volltext

Themen:

Dopamine
Dopamine Plasma Membrane Transport Proteins
Journal Article
Tropanes
VTD58H1Z2X

Anmerkungen:

Date Completed 10.01.2023

Date Revised 21.10.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1097/RLU.0000000000004501

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM351185070